However, published data confirm considerable vascular [33] and metabolic [34] side effects with the use of cyclosporine A. Indeed, in rat cardiac allografts led cyclosporine A to the increase of transplant arteriosclerosis by the up-regulation of the expression of tissue growth factor beta (TGF-b) [35]. Here, TGFB1 is linked to arteriosclerosis.